143 related items for PubMed ID: 3156907
1. Self-reported diurnal mood changes, early morning awakening and the dexamethasone suppression test in endogenous depression.
Grunhaus L, Flegel P, Carroll BJ, Greden JF.
J Affect Disord; 1985; 8(1):1-7. PubMed ID: 3156907
[Abstract] [Full Text] [Related]
2. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test.
Beck-Friis J, Ljunggren JG, Thorén M, von Rosen D, Kjellman BF, Wetterberg L.
Psychoneuroendocrinology; 1985; 10(2):173-86. PubMed ID: 2994141
[Abstract] [Full Text] [Related]
3. Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.
Holsboer F, Gerken A, Steiger A, Fass V.
Acta Psychiatr Scand; 1984 May; 69(5):383-90. PubMed ID: 6730994
[Abstract] [Full Text] [Related]
4. Morning and evening adrenocortical responses to ACTH stimulation in endogenously depressed patients: a preliminary report.
Shimoda K, Yamada N, Hanada K, Tsujimoto T, Takahashi S, Takahashi K.
Jpn J Psychiatry Neurol; 1989 Mar; 43(1):57-62. PubMed ID: 2544755
[Abstract] [Full Text] [Related]
5. The dexamethasone suppression test in patients with mood disorders.
Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR, Weissenburger JE, Crowley GT, Khatami M, Vasavada N.
J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
[Abstract] [Full Text] [Related]
6. Chronic caffeine consumption and the dexamethasone suppression test in depression.
Lee MA, Flegel P, Cameron OG, Greden JF.
Psychiatry Res; 1988 Apr; 24(1):61-5. PubMed ID: 3393618
[Abstract] [Full Text] [Related]
7. Neuroendocrinological aspects of depression and symptomatological picture.
Tosca P, Fenoglio L, Zerbi F, Romani A, Bezzi G, Ferrari E, Canepari C.
Psychiatr Clin (Basel); 1982 Apr; 15(3):153-9. PubMed ID: 7134486
[Abstract] [Full Text] [Related]
8. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone.
Arana GW, Reichlin S, Workman R, Haaser R, Shader RI.
Am J Psychiatry; 1988 Jun; 145(6):707-11. PubMed ID: 3369557
[Abstract] [Full Text] [Related]
9. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
Guthrie SK, Vartanian L, Grunhaus L, Hariharan M, Pande A, Haskett RF.
Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
[Abstract] [Full Text] [Related]
10. Cortisol suppression and circadian rhythm in endogenous depression: a preliminary report.
Lee MA, Taylor MA.
Biol Psychiatry; 1983 Oct; 18(10):1127-32. PubMed ID: 6652153
[Abstract] [Full Text] [Related]
11. Response to dexamethasone and subtype of depression.
Brown WA, Shuey I.
Arch Gen Psychiatry; 1980 Jul; 37(7):747-51. PubMed ID: 7190379
[Abstract] [Full Text] [Related]
12. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
[Abstract] [Full Text] [Related]
13. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
Arch Gen Psychiatry; 1987 Sep 15; 44(9):790-5. PubMed ID: 3632252
[Abstract] [Full Text] [Related]
14. [Influence of depressive history on biological parameters in major depression].
Van Wijnendaele R, Hubain P, Dramaix M, Mendlewicz J, Linkowski P.
Encephale; 2002 Sep 15; 28(1):51-8. PubMed ID: 11963343
[Abstract] [Full Text] [Related]
15. Dexamethasone suppression test in depression with reversible dementia.
Alexopoulos GS, Young RC, Haycox JA, Shamoian CA, Blass JP.
Psychiatry Res; 1985 Dec 15; 16(4):277-85. PubMed ID: 4089057
[Abstract] [Full Text] [Related]
16. Diurnal variation of mood and the cortisol rhythm in depression and normal states of mind.
von Zerssen D, Doerr P, Emrich HM, Lund R, Pirke KM.
Eur Arch Psychiatry Neurol Sci; 1987 Dec 15; 237(1):36-45. PubMed ID: 3428315
[Abstract] [Full Text] [Related]
17. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
Pfohl B, Sherman B, Schlechte J, Stone R.
Arch Gen Psychiatry; 1985 Sep 15; 42(9):897-903. PubMed ID: 2994590
[Abstract] [Full Text] [Related]
18. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
Carson SW, Halbreich U, Yeh CM, Asnis G, Goldstein S.
Biol Psychiatry; 1988 Sep 15; 24(5):569-77. PubMed ID: 3167145
[Abstract] [Full Text] [Related]
19. Depression, negative and positive symptoms, and the DST in schizophrenia.
Minas IH, Jackson HJ, Joshua SD, Burgess PM.
Schizophr Res; 1990 Sep 15; 3(5-6):321-7. PubMed ID: 2282337
[Abstract] [Full Text] [Related]
20. Dexamethasone suppression test response in major depression: stability across hospitalizations.
Coryell W, Schlesser MA.
Psychiatry Res; 1983 Mar 15; 8(3):179-89. PubMed ID: 6574537
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
